SCHEMBL418556

SCHEMBL418556

COC(=O)c1cc(Cl)ccc1NC(=O)Cc1cccc(-c2ccoc2)c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.61
CNR1 P21554 1/20 0.45
POLB P06746 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KCNQ2 O43526 2/20 0.42
SHMT1 P34896 2/20 0.41
SHMT2 P34897 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NR4A2 P43354 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NAT1 P18440 1/20 0.40
P2RY14 Q15391 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL419000 0.90 SERPINE1 (0.60) SERPINE1CNR1KDM4EGAANPC1
SCHEMBL418577 0.89 SERPINE1 (0.73) SERPINE1CNR1POLBKDM4EGAA
SCHEMBL1015802 0.86 SERPINE1 (0.84) SERPINE1CNR1POLBKDM4EGAA
SCHEMBL1016838 0.85 SERPINE1 (0.81) SERPINE1CNR1KDM4EGAANPC1
SCHEMBL419148 0.84 SERPINE1 (0.82) SERPINE1POLBKDM4EGAANPC1
SCHEMBL1012933 0.83 SERPINE1 (0.61) SERPINE1CNR1KDM4EGAAALDH1A1
SCHEMBL1015662 0.83 SERPINE1 (0.64) SERPINE1CNR1POLBKDM4EGAA
SCHEMBL419057 0.82 SERPINE1 (0.78) SERPINE1CNR1NPC1ALDH1A1HPGD
SCHEMBL1015090 0.82 SERPINE1 (0.79) SERPINE1CNR1NPC1ALDH1A1HPGD
SCHEMBL417046 0.81 SERPINE1 (0.47) SERPINE1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2607348-B1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE INC (JP) 2021-03-17 EP disclosed
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO LTD (JP) 2014-10-02 US disclosed
US-8785473-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2014-07-22 US disclosed
EP-2607348-A2 Plasminogen Activator Inhibitor-1 Inhibitor Renascience CO., LTD. (JP) 2013-06-26 EP disclosed
EP-2415755-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR Renascience CO., LTD. (JP) 2012-02-08 EP disclosed
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE CO., LTD. (JP) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885CNR1 3208/4885POLB 2730/4885
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885CNR1 3208/4885POLB 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.